Naini Tāl, India
Naini Tāl, India

Time filter

Source Type

Receive press releases from iHealthcareAnalyst, Inc.: By Email Global Animal Health Care Market Research Reports, Competitive Analytics, Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. Animal Health Care Market reports by iHealthcareAnalyst, Inc. include Animal Blood Plasma Products and Derivatives, Animal Genetic Testing Services, Animal Healthcare, Animal Vaccines, Bovine Respiratory Disease Treatment, Equine Drugs and Supplements, Equine Healthcare, and Foot and Mouth Disease Vaccines. Maryland Heights, MO, May 19, 2017 --( The global animal health care market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global market research reports are divided by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global reports also provide detailed market landscape (market drivers, restraints, opportunities), market attractiveness and profitability analysis as well as profiles of major competitors in the global market which includes company overview, financial snapshot, key products, technologies and services offered, and recent developments. Browse Global Animal Health Care Market Reports, Competitive Analytics, Growth Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. at https://www.ihealthcareanalyst.com/reports/animal-health/ Table of Contents 1. Introduction 2. Executive Summary 2.1. Market Size Estimation (Revenue USD Million, 2014-2021) 2.2. Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021) 3. Research Methodology 4. Market Landscape 4.1. Market Dynamics 4.1.1. Drivers 4.1.2. Barriers 4.1.3. Opportunities 4.2. Market Share Analysis 4.2.1. Companies 4.2.2. Drugs 4.3. Market Trends Analysis 4.3.1. Key success factors 4.3.2. Market Growth Rate 4.4. Market Attractiveness Analysis 4.5. Market Profitability Analysis 4.5.1. Buyer power 4.5.2. Supplier power 4.5.3. Barriers to entry 4.5.4. Threat of substitute products 4.5.5. Rivalry among firms in the industry 4.6. Distribution Channels 5. Market Segmentation 5.1. Animal Species Type 5.2. Product Type (Diagnostic or Therapeutic) 5.3. Diagnostic Test 5.4. Indication Type 5.5. Technology 5.6. Diagnostics, Therapeutic or Surgical Application 5.7. End User Groups 6. Geography (Region, Country) 6.1. North America (U.S., Canada) 6.2. Latin America (Brazil, Mexico, Rest of LA) 6.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 6.4. Asia Pacific (Japan, China, India, Rest of APAC) 6.5. Rest of the World 7. Company Profiles 7.1. Company Overview 7.2. Financial Snapshot (FY 2014-2016) 7.3. Product Portfolio 7.4. Business Strategies 7.5. Recent Developments 8. Recommendations 9. References To request Table of Contents and Sample Pages of these reports visit: https://www.ihealthcareanalyst.com/reports/animal-health/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, May 19, 2017 --( PR.com )-- The published titles of Animal Health Care Market reports by iHealthcareAnalyst, Inc. include Animal Blood Plasma Products and Derivatives, Animal Genetic Testing Services, Animal Healthcare, Animal Vaccines, Bovine Respiratory Disease Treatment, Equine Drugs and Supplements, Equine Healthcare, and Foot and Mouth Disease Vaccines.The global animal health care market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global market research reports are divided by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global reports also provide detailed market landscape (market drivers, restraints, opportunities), market attractiveness and profitability analysis as well as profiles of major competitors in the global market which includes company overview, financial snapshot, key products, technologies and services offered, and recent developments.Browse Global Animal Health Care Market Reports, Competitive Analytics, Growth Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. at https://www.ihealthcareanalyst.com/reports/animal-health/Table of Contents1. Introduction2. Executive Summary2.1. Market Size Estimation (Revenue USD Million, 2014-2021)2.2. Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)3. Research Methodology4. Market Landscape4.1. Market Dynamics4.1.1. Drivers4.1.2. Barriers4.1.3. Opportunities4.2. Market Share Analysis4.2.1. Companies4.2.2. Drugs4.3. Market Trends Analysis4.3.1. Key success factors4.3.2. Market Growth Rate4.4. Market Attractiveness Analysis4.5. Market Profitability Analysis4.5.1. Buyer power4.5.2. Supplier power4.5.3. Barriers to entry4.5.4. Threat of substitute products4.5.5. Rivalry among firms in the industry4.6. Distribution Channels5. Market Segmentation5.1. Animal Species Type5.2. Product Type (Diagnostic or Therapeutic)5.3. Diagnostic Test5.4. Indication Type5.5. Technology5.6. Diagnostics, Therapeutic or Surgical Application5.7. End User Groups6. Geography (Region, Country)6.1. North America (U.S., Canada)6.2. Latin America (Brazil, Mexico, Rest of LA)6.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)6.4. Asia Pacific (Japan, China, India, Rest of APAC)6.5. Rest of the World7. Company Profiles7.1. Company Overview7.2. Financial Snapshot (FY 2014-2016)7.3. Product Portfolio7.4. Business Strategies7.5. Recent Developments8. Recommendations9. ReferencesTo request Table of Contents and Sample Pages of these reports visit:https://www.ihealthcareanalyst.com/reports/animal-health/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


Browse 39 Exhibits, 4 Major Company Profiles, spread across 70 pages available at http://www.reportsnreports.com/reports/994478-global-benign-prostatic-hyperplasia-bph-drugs-market-2017-2021.html. One trend in benign prostatic hyperplasia drugs market is advancements in early-stage diagnosis through new diagnostic methods. New diagnostic methods for BPH are likely to boost the diagnosed patient pool, thereby fueling the market growth. The market has seen the emergence of novel diagnostic tests, which are expected to be more accurate than the conventional PSA blood test. Considering the failure of PSA test to detect early-stage BPH, researchers have been working on new diagnostic methods to improve diagnosis. The following companies as the key players in the global benign prostatic hyperplasia drugs market: Astellas Pharma, Eli Lilly, GlaxoSmithKline, and Sanofi. Other prominent vendors in the market are: ADC Therapeutics, Advaxis, Agennix, ANI Pharmaceuticals, Bayer HealthCare, BHR Pharma, Bristol-Myers Squibb, Boehringer Ingelheim, Dendreo (Valeant Pharmaceuticals), Eisai, Endo Pharmaceuticals, Ferring, Foresee Pharmaceuticals, Io Therapeutics, LIDDS, Madrigal Pharmaceuticals, Merck, Novartis, Nymox Pharmaceutical, Spectrum Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceutical Industries, and Urologix. Order a copy of Global Benign Prostatic Hyperplasia Drugs Market 2017-2021 research report at http://www.reportsnreports.com/purchase.aspx?name=994478. According to the benign prostatic hyperplasia drugs market report, one driver in market is growing geriatric male population. The presence of a large population with BPH symptoms is expected to drive the market growth. The risk of BPH increases exponentially with the rise in the age of an individual. Approximately, 80% of men who reach 60 years and above have mild to strong symptoms of BPH. This disorder affects one in 38 individuals in the age group of 40-59 years; however, in the age group of 60-69 years, it affects one in 14 individuals. Global Foot and Mouth Disease Vaccines Market 2017-2021 - The analysts forecast global foot and mouth disease vaccine market to grow at a CAGR of 8.61% during the period 2017-2021. Global Pneumococcal Vaccine Market 2016-2020 - Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Global Meningococcal Vaccines Market 2016-2020 - Meningitis (meningococcal diseases) is characterized by inflammation of the protective lining (meninges) present around the brain and spinal cord. It can be classified into infectious and non-infectious meningitis. Explore more reports on Pharmaceuticals at http://www.reportsnreports.com/market-research/pharmaceuticals/. ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Browse 39 Exhibits, 4 Major Company Profiles, spread across 70 pages available at http://www.reportsnreports.com/reports/994478-global-benign-prostatic-hyperplasia-bph-drugs-market-2017-2021.html. One trend in benign prostatic hyperplasia drugs market is advancements in early-stage diagnosis through new diagnostic methods. New diagnostic methods for BPH are likely to boost the diagnosed patient pool, thereby fueling the market growth. The market has seen the emergence of novel diagnostic tests, which are expected to be more accurate than the conventional PSA blood test. Considering the failure of PSA test to detect early-stage BPH, researchers have been working on new diagnostic methods to improve diagnosis. The following companies as the key players in the global benign prostatic hyperplasia drugs market: Astellas Pharma, Eli Lilly, GlaxoSmithKline, and Sanofi. Other prominent vendors in the market are: ADC Therapeutics, Advaxis, Agennix, ANI Pharmaceuticals, Bayer HealthCare, BHR Pharma, Bristol-Myers Squibb, Boehringer Ingelheim, Dendreo (Valeant Pharmaceuticals), Eisai, Endo Pharmaceuticals, Ferring, Foresee Pharmaceuticals, Io Therapeutics, LIDDS, Madrigal Pharmaceuticals, Merck, Novartis, Nymox Pharmaceutical, Spectrum Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceutical Industries, and Urologix. Order a copy of Global Benign Prostatic Hyperplasia Drugs Market 2017-2021 research report at http://www.reportsnreports.com/purchase.aspx?name=994478. According to the benign prostatic hyperplasia drugs market report, one driver in market is growing geriatric male population. The presence of a large population with BPH symptoms is expected to drive the market growth. The risk of BPH increases exponentially with the rise in the age of an individual. Approximately, 80% of men who reach 60 years and above have mild to strong symptoms of BPH. This disorder affects one in 38 individuals in the age group of 40-59 years; however, in the age group of 60-69 years, it affects one in 14 individuals. Global Foot and Mouth Disease Vaccines Market 2017-2021 - The analysts forecast global foot and mouth disease vaccine market to grow at a CAGR of 8.61% during the period 2017-2021. Global Pneumococcal Vaccine Market 2016-2020 - Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Global Meningococcal Vaccines Market 2016-2020 - Meningitis (meningococcal diseases) is characterized by inflammation of the protective lining (meninges) present around the brain and spinal cord. It can be classified into infectious and non-infectious meningitis. Explore more reports on Pharmaceuticals at http://www.reportsnreports.com/market-research/pharmaceuticals/. ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Biswal J.K.,Foot and Mouth Disease | Sanyal A.,Foot and Mouth Disease | Rodriguez L.L.,Plum Island Animal Disease Center | Subramaniam S.,Foot and Mouth Disease | And 17 more authors.
Indian Journal of Animal Sciences | Year: 2012

Foot-and-mouth disease (FMD) is a highly contagious and transboundary viral disease of domesticated and wild cloven-hoofed animals. Wide prevalence of the disease in Asia and Africa associated with huge economic loss to the livestock farming and industry has increased the concern worldwide. The disease is a major threat to cattle, buffalo (both milk and meat) and pig production in endemic countries and therefore considered to cause food insecurity, both locally and globally. Currently, 6 serotypes of FMD virus (O, A, Asia-1, SAT-1,-2, and -3) are circulating globally, and serotype C has not been recorded since 1995. In India, the disease is caused by serotypes O, A and Asia-1, of which serotype O is responsible for most of the outbreaks. Emergence and re-emergence of FMD virus genotypes/lineages has been detected in serotypes. Serotype A viruses have been continuously emerging in the nature necessitating frequent replacement of the vaccine strains. The knowledge generated in epidemiology, diagnosis and surveillance of the disease in the country has been instrumental in formulation and implementation of FMD Control Programme through regular 6 monthly vaccination with the aim to create disease free zones in India. The control programme, in operation since X Plan, has resulted in progressive and substantial reduction in occurrence of the disease and DIVA reactors/converters in vaccinated areas. The present review summarizes the disease, the causative agent, and epidemiology of FMD in India and the world.


SINGAPORE, Feb. 14, 2017 /PRNewswire/ -- During the 8th International congress of the Asia Pacific Society of Infection Control (APSIC) in Bangkok, Thailand, leading healthcare company, Mundipharma, will be sponsoring medical educational programs with an international panel to discuss solutions and initiatives to tackle challenges in antimicrobial resistance as well as the importance of proper hygiene practices. At the Congress, Mundipharma will share evidence about how BETADINE® medicines that contain PVPI can be used as a virucide against seasonal infections such as flu, as well as help to prevent infectious disease outbreaks such as MERS, SARS, Ebola, HFMD (Hand Foot and Mouth Disease) and Norovirus in both public and hospital settings. The positive results generated by a leading virologist on PVPI's role against tough to kill viruses and its role in public health will also be presented. In addition, Mundipharma will showcase a digital app as part of its support of the objectives outlined in the WHO's Global Action Plan on Antimicrobial Resistance to improve hygiene measures, reduce infection and limit the use of antibiotics. "Recent global viral outbreaks and the challenges presented by nosocomial infections demonstrate the critical importance of infection control in the race to limit the spread of infections," said Raman Singh, President Mundipharma Asia Pacific, Latin America the Middle East & Africa. "The live demonstration will include an exchange with infection control experts on how digital solutions can drive better hygiene practices to reduce infections and limit the use of antibiotics. In today's highly digitalized world, the app will be a game changer as it will be able to be shared, downloaded and used faster than diseases can spread." "Mundipharma brings to the congress a team of independent experts with deep experience in infection control. They will discuss the appropriate use of antiseptics, antibiotics and hygiene interventions that limit the spread of resistant microorganisms and reduce antimicrobial misuse and overuse, as well as a perspective on the targeted hygiene concept -- aimed at implementing a risk-based approach to hygiene. Mundipharma's independent associated companies are privately owned entities covering the world's pharmaceutical markets. Mundipharma is a prime example of a company that consistently delivers high quality products while standing by the values that represent the company. Our mission is to alleviate the suffering of patients with cancer and non-cancer pain and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients with severe and debilitating diseases the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare. The Asia Pacific Society of Infection Control (APSIC) was established in 1998 and is a multi-national, voluntary, organization dedicated to the advancement of infection control practice to reduce hospital associated infections, monitor and control emerging and re-emerging infectious diseases and improved patient outcomes. APSIC brings together multidisciplinary infection control professionals in the region to share their knowledge, experience, skills, and quality improvement and research findings by facilitating the exchange of information through training courses, seminars, congresses and conferences in the Asia Pacific region. Registered indications differ country to country hence please check with a local Mundipharma office for more information on the local approved prescribing information.


Global Foot and Mouth Disease (FMD) Vaccines Market Analysis: Animals, Vaccines, Growth Trends and Forecast to 2020, New Report by iHealthcareAnalyst, Inc. Foot and Mouth Disease (FMD) Vaccines Market by Animal Types (Cattle, Pigs, Sheep and Goats, Others) and FMD Vaccine Types (Conventional – Al(OH)3-based and Oil-based, and Emergency Vaccines) 2016-2020. Maryland Heights, MO, February 21, 2017 --( Browse Foot and Mouth Disease (FMD) Vaccines Market by Animal Types (Cattle, Pigs, Sheep and Goats, Others) and FMD Vaccine Types (Conventional – Al(OH)3-based and Oil-based, and Emergency Vaccines) 2016-2020 at https://www.ihealthcareanalyst.com/report/foot-and-mouth-disease-vaccines-market/. Foot and Mouth Disease (FMD) is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories (SAT) 1, 2 and 3. The major symptoms of FMD are high fever, sudden weight loss, increased death rate in newborn animals, low conception rate, painful lesions in and around mouth, lips and feet, and excessive salivation. Cloven-hoofed animals especially cattle, pigs, sheep and goats are susceptible to FMD. Vaccination of susceptible animals against foot and mouth disease is a proven strategy for helping to combat the disease since the virus is highly infectious and can be spread by infected animals. The global foot and mouth disease vaccines market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market and also forecasts growth trends (CAGR% - 2016 to 2020). The report also covers the major companies operating in the market and provides detailed market analysis of the different animal types (cattle, pigs, sheep and goats, others) and FMD vaccine types (conventional – Al(OH)3-based and oil-based, and emergency vaccines) available in the global market. The global foot and mouth disease vaccines market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global foot and mouth disease vaccines market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. Major players operating in the global foot and mouth disease vaccines market and included in this report are Agrovet Co., Bayer AG, Biogenesis Bagó, Brilliant Bio Pharma Limited, Indian Immunologicals Ltd., Inova Biotechnologia, Intervac (Pvt.) Ltd., Merial, and Merck Animal Health (MSD). To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/foot-and-mouth-disease-vaccines-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, February 21, 2017 --( PR.com )-- The Foot and Mouth Disease Vaccines market is estimated to reach USD 800 Million in 2020, expanding at a CAGR of 4.6% from 2016 to 2020, due to increased demand for meat and dairy products worldwide. The FMD vaccines traditionally represents the largest share of the veterinary vaccine market worldwide in terms of sales of the entire livestock biological business.Browse Foot and Mouth Disease (FMD) Vaccines Market by Animal Types (Cattle, Pigs, Sheep and Goats, Others) and FMD Vaccine Types (Conventional – Al(OH)3-based and Oil-based, and Emergency Vaccines) 2016-2020 at https://www.ihealthcareanalyst.com/report/foot-and-mouth-disease-vaccines-market/.Foot and Mouth Disease (FMD) is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories (SAT) 1, 2 and 3. The major symptoms of FMD are high fever, sudden weight loss, increased death rate in newborn animals, low conception rate, painful lesions in and around mouth, lips and feet, and excessive salivation. Cloven-hoofed animals especially cattle, pigs, sheep and goats are susceptible to FMD. Vaccination of susceptible animals against foot and mouth disease is a proven strategy for helping to combat the disease since the virus is highly infectious and can be spread by infected animals.The global foot and mouth disease vaccines market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market and also forecasts growth trends (CAGR% - 2016 to 2020). The report also covers the major companies operating in the market and provides detailed market analysis of the different animal types (cattle, pigs, sheep and goats, others) and FMD vaccine types (conventional – Al(OH)3-based and oil-based, and emergency vaccines) available in the global market. The global foot and mouth disease vaccines market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global foot and mouth disease vaccines market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.Major players operating in the global foot and mouth disease vaccines market and included in this report are Agrovet Co., Bayer AG, Biogenesis Bagó, Brilliant Bio Pharma Limited, Indian Immunologicals Ltd., Inova Biotechnologia, Intervac (Pvt.) Ltd., Merial, and Merck Animal Health (MSD).To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/foot-and-mouth-disease-vaccines-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill DriveMaryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com


Rout M.,Foot and Mouth Disease | Biswal J.K.,Foot and Mouth Disease | Dash B.B.,Foot and Mouth Disease | Hegde R.,Foot and Mouth Disease | And 3 more authors.
Indian Journal of Animal Sciences | Year: 2014

The present study was undertaken to investigate foot-and-mouth disease (FMD) outbreaks in various villages of Chikkaballapur district in Karnataka. The disease was recorded in both small and large ruminant population. Serum samples (357) were collected from clinically sick, recovered and in-contact animals, and clinical samples (31) were collected from sick or recovering animals. In 3AB non-structural protein (NSP) ELISA, 42.85% cattle, 59.93% sheep and 73.91% goats were tested positive indicating an extensive FMD virus (FMDV) activity. The serum samples were also tested in liquid phase blocking (LPB) ELISA to assess the protective antibody titre, which were 42.85%, 6.72% and 8.69% for cattle, sheep and goats, respectively. Hence, it is presumed that poor herd immunity might have been one of the contributing factors for the spread of the disease. The outbreaks were caused by FMDV serotype O and Asia 1 as confirmed in serotype differentiating antigen detection ELISA and multiplex PCR. The VP1 region based phylogenetic analysis indicated the involvement of both Ind2001 and recently identified Ind2011 lineage of serotype O and lineage C of serotype Asia 1 in the outbreaks. The study revealed the epidemiological complexity of FMD in the field with respect to the spectrum of species of animals affected and the contemporaneous involvement of multiple serotypes and lineages.


News Article | December 9, 2016
Site: www.businesswire.com

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Hand, Foot and Mouth Disease - Pipeline Review, H2 2016" report to their offering. Hand, Foot and Mouth Disease - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I and Preclinical stages are 1 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 2 molecules, respectively. Hand, Foot and Mouth Disease. Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. For more information about this report visit http://www.researchandmarkets.com/research/3z9d7h/hand_foot_and

Loading Foot and Mouth Disease collaborators
Loading Foot and Mouth Disease collaborators